Centre Antoine Lacassagne
Clinical trials sponsored by Centre Antoine Lacassagne, explained in plain language.
-
New drug combo aims to tame aggressive leukemia
Disease control OngoingThis study is testing a combination of three drugs for adults with a specific type of acute myeloid leukemia (AML) that has returned after treatment or did not respond to initial therapy. The goal is to see if adding a newer targeted drug (gilteritinib) to two existing drugs is s…
Phase: PHASE2 • Sponsor: Centre Antoine Lacassagne • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Radiation breakthrough could let rectal cancer patients skip surgery, keep their rectum
Disease control OngoingThis study is testing whether a specific type of internal radiation boost (called CXB) given after standard chemo-radiation is better than an external radiation boost at helping patients with early rectal cancer avoid major surgery that removes the rectum or requires a permanent …
Phase: PHASE3 • Sponsor: Centre Antoine Lacassagne • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC